全文获取类型
收费全文 | 2457篇 |
免费 | 305篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 84篇 |
妇产科学 | 50篇 |
基础医学 | 352篇 |
口腔科学 | 52篇 |
临床医学 | 384篇 |
内科学 | 352篇 |
皮肤病学 | 42篇 |
神经病学 | 117篇 |
特种医学 | 275篇 |
外科学 | 311篇 |
综合类 | 75篇 |
一般理论 | 1篇 |
预防医学 | 270篇 |
眼科学 | 11篇 |
药学 | 222篇 |
中国医学 | 1篇 |
肿瘤学 | 181篇 |
出版年
2021年 | 27篇 |
2020年 | 33篇 |
2019年 | 27篇 |
2018年 | 45篇 |
2017年 | 27篇 |
2016年 | 39篇 |
2015年 | 32篇 |
2014年 | 71篇 |
2013年 | 55篇 |
2012年 | 94篇 |
2011年 | 87篇 |
2010年 | 59篇 |
2009年 | 51篇 |
2008年 | 66篇 |
2007年 | 104篇 |
2006年 | 87篇 |
2005年 | 84篇 |
2004年 | 83篇 |
2003年 | 70篇 |
2002年 | 74篇 |
2001年 | 59篇 |
2000年 | 67篇 |
1999年 | 77篇 |
1998年 | 60篇 |
1997年 | 68篇 |
1996年 | 58篇 |
1995年 | 52篇 |
1994年 | 37篇 |
1993年 | 40篇 |
1992年 | 46篇 |
1991年 | 63篇 |
1990年 | 52篇 |
1989年 | 59篇 |
1988年 | 82篇 |
1987年 | 65篇 |
1986年 | 54篇 |
1985年 | 57篇 |
1984年 | 40篇 |
1983年 | 38篇 |
1982年 | 37篇 |
1981年 | 30篇 |
1980年 | 38篇 |
1979年 | 40篇 |
1978年 | 37篇 |
1977年 | 40篇 |
1976年 | 33篇 |
1975年 | 33篇 |
1974年 | 20篇 |
1972年 | 24篇 |
1970年 | 21篇 |
排序方式: 共有2783条查询结果,搜索用时 16 毫秒
101.
102.
Corey Heitz Justin Morgenstern Christopher Bond William K. Milne 《Academic emergency medicine》2020,27(1):64-65
The Office of the Inspector General has the authority to levy fines relating to violations of the Emergency Medicine Treatment and Labor Act (EMTALA) for both medical and psychiatric care. Terp et al. have described the incidence of violations and penalties levied for psychiatric cases and compared them to that for medical. This article reviews that article and the podcast recorded with Dr. Terp and the ensuing discussion in the podcast and online. 相似文献
103.
104.
S. Ghazaleh Dashti Julie A. Simpson Amalia Karahalios Vivian Viallon Margarita Moreno-Betancur Lyle C. Gurrin Robert J. MacInnis Brigid M. Lynch Laura Baglietto Howard A. Morris Marc J. Gunter Pietro Ferrari Roger L. Milne Graham G. Giles Dallas R. English 《International journal of cancer. Journal international du cancer》2020,146(6):1541-1552
Adiposity increases estrogen receptor (ER)-positive postmenopausal breast cancer risk. While mechanisms underlying this relationship are uncertain, dysregulated sex-steroid hormone production and insulin signaling are likely pathways. Our aim was to quantify mediating effects of fasting insulin and free estradiol in the adiposity and ER-positive postmenopausal breast cancer association. We used data from a case–cohort study of sex hormones and insulin signaling nested within the Melbourne Collaborative Cohort Study. Eligible women, at baseline, were not diagnosed with cancer, were postmenopausal, did not use hormone therapy and had no history of diabetes or diabetes medication use. Women with ER-negative disease or breast cancer diagnosis within the first follow-up year were excluded. We analyzed the study as a cumulative sampling case–control study with 149 cases and 1,029 controls. Missing values for insulin and free estradiol were multiply imputed with chained equations. Interventional direct (IDE) and indirect (IIE) effects were estimated using regression-based multiple-mediator approach. For women with body mass index (BMI) >30 kg/m2 compared to women with BMI 18.5–25 kg/m2, the risk ratio (RR) of breast cancer was 1.75 (95% confidence interval [CI] 1.05–2.91). The estimated IDE (RR) not through the mediators was 1.03 (95% CI 0.43–2.48). Percentage mediated effect through free estradiol was 72% (IIE-RR 1.56; 95% CI 1.11–2.19). There was no evidence for an indirect effect through insulin (IIE-RR 1.12; 95% CI 0.68–1.84; 28% mediated). Our results suggest that circulating free estradiol plays an important mediating role in the adiposity–breast cancer relationship but does not explain all of the association. 相似文献
105.
Tuong L. Nguyen Shuai Li Gillian S. Dite Ye K. Aung Christopher F. Evans Ho N. Trinh Laura Baglietto Jennifer Stone Yun-Mi Song Joohon Sung Dallas R. English Mark A. Jenkins Pierre-Antoine Dugué Roger L. Milne Melissa C. Southey Graham G. Giles Malcolm C. Pike John L. Hopper 《International journal of cancer. Journal international du cancer》2020,147(2):375-382
Interval breast cancers (those diagnosed between recommended mammography screens) generally have poorer outcomes and are more common among women with dense breasts. We aimed to develop a risk model for interval breast cancer. We conducted a nested case–control study within the Melbourne Collaborative Cohort Study involving 168 interval breast cancer patients and 498 matched control subjects. We measured breast density using the CUMULUS software. We recorded first-degree family history by questionnaire, measured body mass index (BMI) and calculated age-adjusted breast tissue aging, a novel measure of exposure to estrogen and progesterone based on the Pike model. We fitted conditional logistic regression to estimate odds ratio (OR) or odds ratio per adjusted standard deviation (OPERA) and calculated the area under the receiver operating characteristic curve (AUC). The stronger risk associations were for unadjusted percent breast density (OPERA = 1.99; AUC = 0.66), more so after adjusting for age and BMI (OPERA = 2.26; AUC = 0.70), and for family history (OR = 2.70; AUC = 0.56). When the latter two factors and their multiplicative interactions with age-adjusted breast tissue aging (p = 0.01 and 0.02, respectively) were fitted, the AUC was 0.73 (95% CI 0.69–0.77), equivalent to a ninefold interquartile risk ratio. In summary, compared with using dense breasts alone, risk discrimination for interval breast cancers could be doubled by instead using breast density, BMI, family history and hormonal exposure. This would also give women with dense breasts, and their physicians, more information about the major consequence of having dense breasts—an increased risk of developing an interval breast cancer. 相似文献
106.
Chlamydia A in the female genital tract 总被引:14,自引:0,他引:14
107.
Measurements were made from the human first dorsal interosseous and extensor digitorum communis muscles of the surface electromyographic activity reflexly produced by brief stretch of the muscle. For the first dorsal interosseous muscle, reflex EMG activity was also produced by electrical stimulation of the ulnar nerve at the wrist. The procedures were carried out before, during, and after 25 min of nonspecific, low-frequency electrical stimulation to the contralateral arm delivered through intramuscular electrodes. Control stimulation was delivered subcutaneously. The EMG recorded during a maintained contraction was rectified, filtered, and averaged. Two reflex components (M1 and M2) of the EMG response to muscle stretch or ulnar nerve stimulation were investigated. During nonspecific intramuscular stimulation to the contralateral arm, M1 responses of the extensor digitorum communis were depressed, initially by 37%. The effect began to fade during stimulation but extended beyond it. Reflex responses were elicited alternately by brief stretch of the first dorsal interosseus muscle and by electrical stimulation of the ulnar nerve in the same experiment. Nonspecific intramuscular stimulation to the contralateral arm depressed the M1 response to stretch, but had no effect on the M1 response to electrical stimulation. It is concluded that nonspecific intramuscular electrical stimulation reduces the amplitude of the M1 component of the response to brief stretch of contralateral muscle, either through depression of fusimotor activity or inhibition of oligosynaptic pathways that contribute to the early reflex response. 相似文献
108.
109.
Sarah I. Sheikh Ivan Nestorov Heidy Russell John O’Gorman Ron Huang Ginger L. Milne Robert H. Scannevin Mark Novas Katherine T. Dawson 《Clinical therapeutics》2013
Background
Delayed-release dimethyl fumarate (DR-DMF) has cytoprotective and antiinflammatory properties and has recently been approved in the United States as an oral treatment for relapsing forms of multiple sclerosis. The most common adverse events associated with DR-DMF are flushing and gastrointestinal (GI) events, the incidences of which diminish over time.Objective
The purpose of this study was to evaluate the tolerability and pharmacokinetic (PK) profile of DR-DMF with or without concomitant acetylsalicylic acid (aspirin), a cyclooxygenase inhibitor.Methods
Healthy volunteers (N = 56) were randomized to receive different dosing regimens of DR-DMF or matching placebo with or without pretreatment with 325 mg aspirin for 4 days. Plasma levels of the active metabolite monomethyl fumarate were assessed on days 1 and 4. Flushing and GI events were assessed using patient-reported scales. Potential flushing mediators were explored.Results
DR-DMF showed a safety, tolerability, and PK profile consistent with previous clinical experience, with no evidence of accumulation. Pretreatment with aspirin had no effect on the primary PK parameters, AUC0–10h, or Cmax. Flushing severity, assessed by 2 subject-reported rating scales, was generally mild and was rated highest at the start of treatment. Pretreatment with aspirin reduced flushing incidence and intensity without affecting GI events or the PK profile of DR-DMF. In some DR-DMF–treated individuals, plasma concentrations of a prostaglandin D2 (PGD2) metabolite were increased.Conclusions
In healthy volunteers, DR-DMF was well tolerated over 4 days of dosing, with a PK profile consistent with that previously reported and no evidence of accumulation. Aspirin pretreatment reduced the incidence and intensity of flushing without affecting GI events or the DR-DMF PK profile. Elevated levels of PGD2 in some DR-DMF–treated individuals suggest that flushing may be, at least in part, prostaglandin mediated. ClinicalTrials.gov identifier: ID: NCT01281111. 相似文献110.
G. L. NIELSEN K. L. FAARVANG† B. S. THOMSEN‡ K. L. TEGLBJÆRG L. T. JENSEN‡ T. M. HANSEN† H. H. LERVANG§ E. B. SCHMIDT§ J. DYERBERG¶ E. ERNST§ 《European journal of clinical investigation》1992,22(10):687-691
STUDY OBJECTIVE: To determine the effect of dietary supplementation with n-3 polyunsaturated fatty acids (n-3 PUFA) on disease variables in patients with rheumatoid arthritis. DESIGN: Multicenter, randomized, placebo controlled, double blind. SETTING: Three Danish hospital Departments of Rheumatology. PATIENTS: Fifty-one patients with active rheumatoid arthritis. INTERVENTION: Random allocation to 12 weeks of treatment with either six n-3 PUFA capsules (3.6 g) or six capsules with fat composition as the average Danish diet. MAIN RESULTS: Significant improvement of morning stiffness and joint tenderness. No significant effect on the four other assessed clinical parameters. No serious side effects. CONCLUSIONS: Dietary supplementation with n-3 PUFA in patients with rheumatoid arthritis improved two out of six patient reported disease parameters. Further studies are needed to clarify the more precise role of n-3 PUFA in the treatment of rheumatoid arthritis. 相似文献